Navigation Links
Fuel cells utilised to produce electricity from process industry by-product hydrogen
Date:6/17/2014

VTT Technical Research Centre of Finland has developed a pilot-scale power plant based on fuel cells that utilises by-product hydrogen from the process industry. The power plant has been in operation at Kemira Chemicals Oy's site in Finland since January 2014. The system produces electricity from hydrogen generated as a by-product of a sodium chlorate process at a high electric efficiency and is the first of its kind in the Nordic Countries.

When scaled into commercial size, the equipment enables the reduction of energy consumption of the electrolysis process used for sodium chlorate production by 10%. The Kemira site's annual electricity consumption is approximately 578 GWh.

A few similar plants have been built elsewhere in the world, for example in the Netherlands and North America. The electric power of the pilot plant is approximately 50 kW. The total electrical efficiency of the system, including the fuel utilisation ratio and the power losses due to auxiliary equipment and power electronics, is approximately 44%, while the fuel cell itself is operating at an electrical efficiency of 54%. The power plant is based on PEM fuel cells - the same technology that is considered most promising for the fuel cell vehicles.

At the moment, the low-temperature fuel cell at the Kemira Chemicals site operates at approximately 60 C. In the future, utilization of the waste heat produced by the system is expected to also improve. This is achieved through development of fuel cell materials, which enable higher operating temperatures. One goal of the DuraDemo project, coordinated by VTT, has been to gather user experience of operating a fuel cell system in an actual end-user application in an industrial environment. The system performance has been recorded and analysed to confirm the assumed level of readiness of PEMFC from technological and commercial point of view and dealing with potential unresolved problems related to this in the by-product hydrogen application.

The project also provided important information on the reliability of the auxiliary systems and components, and the impact of using industrial-quality hydrogen in PEM fuel cells. The strict quality standards governing the utilisation of hydrogen as traffic fuel today are an important factor in the price formation of hydrogen. In the future, a re-evaluation of these standards may facilitate a major drop in the producer price of hydrogen.


'/>"/>

Contact: Timo Keränen
timo.keranen@vtt.fi
358-405-658-390
VTT Technical Research Centre of Finland
Source:Eurekalert

Related biology news :

1. Stem cells in neurodegeneration: challenges and future neurotherapeutic prospects
2. Proliferation cues natural killer cells for job change
3. Guidelines needed for creating germ cells in vitro, Cornell, JAX scientists state
4. Coral, human cells linked in death
5. New class of nanoparticle brings cheaper, lighter solar cells outdoors
6. Specific protein may help beta cells survive in type 1 diabetes
7. Tangled path of Alzheimers-linked brain cells mapped in mice
8. Scientists reveal details of calcium safety-valve in cells
9. Stem cells hold keys to bodys plan
10. Stem cells found to play restorative role when affecting brain signaling process
11. First demonstration in human cells of chromosomal translocations that cause certain cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2016)... 2, 2016   The Weather Company , an IBM ... an industry-first capability in which consumers will be able to ... ask questions via voice or text and receive relevant information ... Marketers have long sought an advertising solution that ... be personal, relevant and valuable; and can scale across millions ...
(Date:5/24/2016)... 2016 Ampronix facilitates superior patient care by providing unparalleled technology to leaders ... is the latest premium product recently added to the range of products distributed by ... ... ... LCD Medical Display- Ampronix News ...
(Date:5/12/2016)... WearablesResearch.com , a brand of Troubadour ... from the Q1 wave of its quarterly wearables survey. ... receptivity to a program where they would receive discounts ... company. "We were surprised to see that ... LaColla , CEO of Troubadour Research, "primarily because there ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... OTTAWA, ON (PRWEB) , ... June 23, 2016 , ... ... former DNA Technical Leader at the Arkansas State Crime Laboratory, has joined STACS DNA ... joining the STACS DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. ...
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
(Date:6/23/2016)... June 23, 2016 ... 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 Published recently ... peer-reviewed journal from touchONCOLOGY, Andrew D Zelenetz ... of cancer care is placing an increasing burden ... expensive biologic therapies. With the patents on many ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, ... Pennsylvania Convention Center and will showcase its product’s latest features from June 26 ... presenting a scientific poster on Disrupting Clinical Trials in The Cloud during the ...
Breaking Biology Technology: